{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:50:40Z","timestamp":1788871840955,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003035","name":"Aase og Ejnar Danielsens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.bcp.2012.10.015","type":"journal-article","created":{"date-parts":[[2012,10,24]],"date-time":"2012-10-24T14:47:22Z","timestamp":1351090042000},"page":"115-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Interorgan metabolism of ornithine phenylacetate (OP)\u2014A novel strategy for treatment of hyperammonemia"],"prefix":"10.1016","volume":"85","author":[{"given":"Sherry","family":"Dadsetan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse K.","family":"Bak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Vilstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Schousboe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Jalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Keiding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle S.","family":"Waagepetersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2012.10.015_bib0005","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0301-0082(02)00019-9","article-title":"Neurobiology of ammonia","volume":"67","author":"Felipo","year":"2002","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.bcp.2012.10.015_bib0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0197-0186(02)00040-2","article-title":"Interorgan ammonia metabolism in liver failure","volume":"41","author":"Olde Damink","year":"2002","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bcp.2012.10.015_bib0015","doi-asserted-by":"crossref","first-page":"G269","DOI":"10.1152\/ajpgi.00062.2011","article-title":"Branched-chain amino acids increase arterial blood ammonia in spite of enhanced intrinsic muscle ammonia metabolism in patients with cirrhosis and healthy subjects","volume":"301","author":"Dam","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.bcp.2012.10.015_bib0020","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.mehy.2006.12.061","article-title":"l-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy","volume":"69","author":"Jalan","year":"2007","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.bcp.2012.10.015_bib0025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11011-008-9122-5","article-title":"Interorgan ammonia trafficking in liver disease","volume":"24","author":"Olde Damink","year":"2009","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.bcp.2012.10.015_bib0030","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1056\/NEJMoa066596","article-title":"Survival after treatment with phenylacetate and benzoate for urea-cycle disorders","volume":"356","author":"Enns","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2012.10.015_bib0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/hep.22897","article-title":"l-Ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats","volume":"50","author":"Davies","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2012.10.015_bib0040","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/hep.22917","article-title":"l-Ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure","volume":"50","author":"Ytrebo","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2012.10.015_bib0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jhep.2011.06.026","article-title":"Ornithine phenylacetate prevents disturbances of motor-evoked potentials induced by intestinal blood in rats with portacaval anastomosis","volume":"56","author":"Oria","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.bcp.2012.10.015_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(24)37027-2","article-title":"Treatment of cirrhotic rats with l-ornithine-l-aspartate enhances urea synthesis and lowers serum ammonia levels","volume":"283","author":"Gebhardt","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2012.10.015_bib0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11011-008-9123-4","article-title":"Metabolic fate of isoleucine in a rat model of hepatic encephalopathy and in cultured neural cells exposed to ammonia","volume":"24","author":"Bak","year":"2009","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.bcp.2012.10.015_bib0060","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1478-3231.2009.02034.x","article-title":"Experimental models of hepatic encephalopathy: ISHEN guidelines","volume":"29","author":"Butterworth","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.bcp.2012.10.015_bib0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2174\/1389450003349254","article-title":"Ornithine aminotransferase. a potential target for the treatment of hyperammonemias","volume":"1","author":"Seiler","year":"2000","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.bcp.2012.10.015_bib0070","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0021-9258(17)40648-X","article-title":"Effect of aspartate on complexes between glutamate dehydrogenase and various aminotransferases","volume":"252","author":"Fahien","year":"1977","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.10.015_bib0075","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1212\/WNL.30.2.178","article-title":"Urea cycle regulation. I. Coupling of ornithine metabolism to mitochondrial oxidative phosphorylation","volume":"30","author":"Stumpf","year":"1980","journal-title":"Neurology"},{"key":"10.1016\/j.bcp.2012.10.015_bib0080","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1023\/A:1020613314572","article-title":"l-ornithine-l-aspartate in experimental portal-systemic encephalopathy: therapeutic efficacy and mechanism of action","volume":"13","author":"Rose","year":"1998","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.bcp.2012.10.015_bib0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1124\/dmd.32.1.10","article-title":"New secondary metabolites of phenylbutyrate in humans and rats","volume":"32","author":"Kasumov","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2012.10.015_bib0090","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1471-4159.1984.tb09691.x","article-title":"Changes in the amino acid content of nerve endings (synaptosomes) induced by drugs that alter the metabolism of glutamate and gamma-aminobutyric acid","volume":"42","author":"Geddes","year":"1984","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2012.10.015_bib0095","first-page":"3047","article-title":"A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule","volume":"7","author":"Carducci","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2012.10.015_bib0100","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0009-8981(74)90223-X","article-title":"A kinetic determination of ammonia in plasma","volume":"56","author":"van Anken","year":"1974","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.bcp.2012.10.015_bib0105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.10.015_bib0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0021-9673(01)90333-4","article-title":"Analysis of amino acids as their tert-butyldimethylsilyl derivatives by gas\u2013liquid chromatography and mass spectrometry","volume":"358","author":"Mawhinney","year":"1986","journal-title":"J Chromatogr"},{"key":"10.1016\/j.bcp.2012.10.015_bib0115","series-title":"Organic chemistry applications","article-title":"Mass spectrometry","author":"Biemann","year":"1962"},{"key":"10.1016\/j.bcp.2012.10.015_bib0120","doi-asserted-by":"crossref","first-page":"e36322","DOI":"10.1371\/journal.pone.0036322","article-title":"Impairment of the organization of locomotor and exploratory behaviors in bile duct-ligated rats","volume":"7","author":"Leke","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2012.10.015_bib0125","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1172\/JCI109322","article-title":"The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia","volume":"63","author":"Lockwood","year":"1979","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2012.10.015_bib0130","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1023\/A:1020741226752","article-title":"Effect of portacaval anastomosis on glutamine synthetase protein and gene expression in brain, liver and skeletal muscle","volume":"14","author":"Desjardins","year":"1999","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.bcp.2012.10.015_bib0135","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/BF01300297","article-title":"Effect of portacaval anastomosis on glutamine synthetase activities in liver, brain, and skeletal muscle","volume":"37","author":"Girard","year":"1992","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bcp.2012.10.015_bib0140","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/hep.510300311","article-title":"l-Ornithine-l-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure","volume":"30","author":"Rose","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2012.10.015_bib0145","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0168-8278(05)80553-7","article-title":"Effects of ornithine aspartate on plasma ammonia and plasma amino acids in patients with cirrhosis. A double-blind, randomized study using a four-fold crossover design","volume":"19","author":"Staedt","year":"1993","journal-title":"J Hepatol"},{"key":"10.1016\/j.bcp.2012.10.015_bib0150","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/hep.510250609","article-title":"Therapeutic efficacy of l-ornithine-l-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study","volume":"25","author":"Kircheis","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2012.10.015_bib0155","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0168-8278(98)80237-7","article-title":"Oral l-ornithine-l-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study","volume":"28","author":"Stauch","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.bcp.2012.10.015_bib0160","series-title":"14th ISHEN symposium","article-title":"Ornithine phenylacetate substantially improves glutamine synthetase and glutaminase expression and activity in multiple organs in cirrhotic rats: additional insights on mechanism of action","author":"Jover-Cobos","year":"2010"},{"key":"10.1016\/j.bcp.2012.10.015_bib0165","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0009-2797(84)90120-0","article-title":"Hepatocyte heterogeneity in ammonia metabolism: impairment of glutamine synthesis in CCl4 induced liver cell necrosis with no effect on urea synthesis","volume":"48","author":"Haussinger","year":"1984","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bcp.2012.10.015_bib0170","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0065-2571(86)90013-0","article-title":"Regulation of hepatic ammonia metabolism: the intercellular glutamine cycle","volume":"25","author":"Haussinger","year":"1986","journal-title":"Adv Enzyme Reg"},{"key":"10.1016\/j.bcp.2012.10.015_bib0175","doi-asserted-by":"crossref","first-page":"61S","DOI":"10.3945\/ajcn.2009.27462Z","article-title":"Hepatic glutamate metabolism: a tale of 2 hepatocytes","volume":"90","author":"Brosnan","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.bcp.2012.10.015_bib0180","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11011-008-9124-3","article-title":"Gut ammonia production and its modulation","volume":"24","author":"Romero-Gomez","year":"2009","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.bcp.2012.10.015_bib0185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1098\/rspb.1972.0064","article-title":"The conjugation of phenylacetic acid in man, sub-human primates and some non-primate species","volume":"182","author":"James","year":"1972","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"10.1016\/j.bcp.2012.10.015_bib0190","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0021-9258(18)70632-7","article-title":"Synthesis of phenylacetylglutamine by human tissue","volume":"229","author":"Moldave","year":"1957","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.10.015_bib0195","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/hep.23589","article-title":"Pharmacology and safety of glycerol phenylbutyrate in healthy adults and adults with cirrhosis","volume":"51","author":"McGuire","year":"2010","journal-title":"Hepatology"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295212006910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295212006910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:56:13Z","timestamp":1757768173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295212006910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0006295212006910"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2012.10.015","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interorgan metabolism of ornithine phenylacetate (OP)\u2014A novel strategy for treatment of hyperammonemia","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2012.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}